About DORZEC-T Eye Drops
DORZEC-T Eye Drops combine Dorzolamide Hydrochloride 2% and Timolol Maleate 0.5%, formulated for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers alone. Clinical data shows intraocular pressure reduction was greater in the combination group than in the Dorzolamide-only and Timolol-only groups. DORZEC-T is manufactured by I Smith at our WHO-GMP certified facility in Baddi, Himachal Pradesh, for supply to hospitals, retail pharmacies, and export partners.
How It Works
- Dorzolamide — inhibits carbonic anhydrase in the ciliary process, leading to a reduction of aqueous humour production, effective in lowering IOP in patients with open-angle glaucoma or ocular hypertension
- Timolol — a non-specific beta blocker that decreases intraocular pressure by reducing aqueous humor formation
Indications
- Elevated intraocular pressure (IOP) with open-angle glaucoma or ocular hypertension in patients insufficiently responsive to beta-blockers
DORZEC-T vs DORZEC
DORZEC-T adds Timolol Maleate to the base Dorzolamide formulation for patients needing combination therapy, showing greater IOP reduction than either Dorzolamide or Timolol used alone. DORZEC contains Dorzolamide alone, suited as monotherapy for patients who don’t require the added beta-blocker.
Why Source DORZEC-T from I Smith
- WHO-GMP certified manufacturing unit in Baddi, Himachal Pradesh
- Competitive bulk and wholesale pricing
- Consistent batch quality with full documentation support
- Third-party / contract manufacturing available
- Pan-India and export supply capability
Frequently Asked Questions
What is DORZEC-T Eye Drops used for?
It is used for elevated intraocular pressure in open-angle glaucoma or ocular hypertension in patients insufficiently responsive to beta-blockers alone.
Why combine Dorzolamide with Timolol?
Combining the two agents reduces aqueous humor through two different mechanisms — Dorzolamide by inhibiting carbonic anhydrase, and Timolol by beta-blockade — and has shown greater IOP reduction than either drug used alone, both at morning trough and morning peak measurements.
What is the composition and packing of DORZEC-T Eye Drops?
Each ml contains Dorzolamide Hydrochloride IP 2% and Timolol Maleate IP 0.5%, in a 5ml bottle.
Is DORZEC-T available for bulk or export orders?
Yes, I Smith supplies DORZEC-T Eye Drops in bulk for domestic distribution and export, along with third-party manufacturing options.
Bulk Order & Manufacturing Enquiry
Planning to stock DORZEC-T Eye Drops for your pharmacy or distribution network? Use the Enquire Now form below to send us your requirement or drop us a message on WhatsApp or simply call +91 98759 13317. Our team will get back to you with pricing, MOQ and product documentation.
Disclaimer: I Smith is an Ophthalmic pharmaceutical manufacturing company in India, providing B2B business solutions. Our ophthalmic products are meant for hospitals, distributors and pharmacies and are not sold directly to individual consumers.
